About us


Origimm (‘Origins of Immunity’) is a private Austrian biotechnology company, which specializes in the discovery of antigens and dermatological drug targets against diseases induced by the skin colonizing bacteria.

The company uses its proprietary technology to identify highly protective antigens and therapeutic targets by reverse functional screening, thereby significantly improving the success in the selection of the most effective preventive and therapeutic product candidates.

continue reading…